Overview

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Gaboxadol